Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02929017 · ClinicalTrials.gov registry record · NA

Integrating Palliative Care for Patients With Idiopathic Pulmonary Fibrosis and Their Caregivers

A NA study, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
140
Enrollment target

NCT02929017 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 140 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02929017, a NA study, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
140 participants
Enrollment target

Study Summary

Patients with Idiopathic Pulmonary Fibrosis (IPF) and their caregivers will be randomized to receive this intervention or usual care. The intervention will include information about the disease, self-management strategies, and introduction to advanced care planning in a format with enhanced content available across multiple domains (face-to-face, printed material, digital (tablet) delivered by an interventionist. The usual care group will be provided with routine printed patient education. At the end of life, IPF patients and their caregivers experience stress, symptom burden, poor quality of life, and inadequate preparedness for end-of-life care planning. The proposed study will measure feasibility, acceptability, and impact of a Supportive Care intervention.

Interventions

  • OTHER SUPPORT
  • OTHER Currently Available Printed Material

Trial Details

FieldValue
Enrollment Target 140 participants
Start Date 2017-03-23
Est. Completion 2020-06-24
Phase NA

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT02929017

The ClinicalTrials.gov registry entry for NCT02929017 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which SUPPORT is the first listed.

NCT02929017 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02929017 about?

NCT02929017 is a clinical study titled "Integrating Palliative Care for Patients With Idiopathic Pulmonary Fibrosis and Their Caregivers". Patients with Idiopathic Pulmonary Fibrosis (IPF) and their caregivers will be randomized to receive this intervention or usual care. The intervention will include information about the disease, self-management strategies, and introduction to advanced care planning in a format with enhanced content ...

What is the current status of trial NCT02929017?

This trial is currently completed. It is a NA study. The enrollment target is 140 participants. The study started on 2017-03-23. Estimated completion is 2020-06-24.

What interventions are being tested in trial NCT02929017?

The interventions under investigation include: SUPPORT (OTHER), Currently Available Printed Material (OTHER).

Who is sponsoring clinical trial NCT02929017?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.